Skip to content
Open access

Shared etiology of late- and adult-onset multiple sclerosis.

Aug 2026 · Multiple Sclerosis · pp. 13524585261472320 · 0 citations · 17 references
Medicine

TL;DR

Most MS risk factors, including MS heredity, HLA-DRB1*15:01, Epstein-Barr nuclear antigen levels, smoking, and low sun exposure, were associated with both onset groups, with stronger effects in AOMS.

Abstract

Background

Late-onset multiple sclerosis (LOMS), defined as disease onset at or after 50 years, is increasingly recognized and associated with distinct features. However, it remains unclear whether LOMS differs etiologically from adult-onset multiple sclerosis (AOMS).

Objectives

To determine whether established MS risk factors differ between LOMS and AOMS and influence age at onset.

Methods

We conducted a Swedish population-based case-control study including 3950 incident MS cases and 7340 controls. Cases were classified as LOMS (n = 396) or AOMS (n = 3554). Associations between risk factors and LOMS and AOMS were estimated using logistic regression. Case-only analyses assessed associations with age at onset.

Results

Most MS risk factors, including MS heredity, HLA-DRB1*15:01, Epstein-Barr nuclear antigen (EBNA)-1 antibody levels, smoking, and low sun exposure, were associated with both onset groups, with stronger effects in AOMS. Elevated body mass index at age 20 years was associated with AOMS, while estimates in LOMS were imprecise. Case-only analyses showed no association with disease timing. Exposure distribution varied across birth cohorts, suggesting cohort effects.

Conclusion

Established MS risk factors appear to be more clearly related to disease susceptibility than to timing of onset. The broadly consistent risk factor profiles support a shared etiology, although modest differences cannot be excluded.

Read PDF

Similar papers

Open access Sep 2026

Late-onset versus adult-onset multiple sclerosis: A comparative analysis of clinical, radiological, and confirmed disability progression.

BACKGROUND Multiple sclerosis (MS) is a chronic, immune-mediated disorder of the central nervous system (CNS). In Egypt, its occurrence is approximately 13.7 per 100,000 inhabitants. The average age of onset for relapsing-remitting MS (RRMS) is between the second and fourth decades of life. OBJECTIVES To determine th...

A. Fouad, Abdallah Saad, Hadeer Mohamed Abd El-Aziz et al. · 0 citations
Open access Sep 2026

Family history of multiple sclerosis and long-term outcomes

Family history is a well-established risk factor for multiple sclerosis (MS), but its influence on disease progression remains unclear. We investigated whether familial MS, including degree of relatedness, is associated with baseline characteristics and disease outcomes. We included individuals with incident MS from th...

A. Hedström, Tomas Olsson, L. Alfredsson · 0 citations
Open access Sep 2026

Distinct clinical phenotypes of late onset and early onset epilepsies.

OBJECTIVE Despite representing the most common and fastest growing form of epilepsy in older adults, the clinical features of late onset epilepsy (LOE) and how it differs from early onset epilepsy (EOE) remain largely underexplored. Therefore, we evaluate the characteristics and risk factors of LOE compared to EOE. M...

Syeda Amrah Hashmi, Mark Quigg, M. Abbas et al. · 0 citations
Open access Aug 2026

Chronic low-grade inflammation, genetic susceptibility, and the risk of multiple sclerosis: a prospective cohort study

Background Immune dysregulation is central to multiple sclerosis (MS) pathogenesis, yet prospective evidence linking peripheral low-grade inflammation (LGI) to MS risk remains limited and inconsistent. We investigated the association of LGI with incident MS risk and MS-related brain structural measures in a large prosp...

Yi-Zhou Cai, Yu-Jia Bao, Yong-Xuan Li et al. · 0 citations
Open access Aug 2026

Predictors of subsequent relapse-independent progression after high-efficacy therapy in relapsing multiple sclerosis

Background and objectives Progression independent of relapse activity (PIRA) is increasingly recognized as a major driver of disability accumulation in multiple sclerosis (MS). However, the factors associated with PIRA occurring after initiation of high-efficacy therapies (HETs) remain poorly investigated. We aimed to...

M. Foschi, A. Surcinelli, I. Panzera et al. · 0 citations
Open access Sep 2026

Clinical and laboratory differences between early- and late-onset systemic sclerosis: A comparative analytical study.

Objective: To compare the clinical and laboratory changes between early- and late-onset systemic sclerosis. Study Design: Comparative Analytical Cross-sectional study. Setting: Fauji Foundation Hospital (FFH), Rawalpindi (RWP). Period: 1st September, 2025 to February, 2026. Methods: A non-probability consecutive sampli...

Madiha Noor, Tehreem Sultana Hamid, Shahida Perveen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.